For those who face the persistent challenge of nicotine addiction, change can often feel out of reach. Yet, new clinical research on psilocybin reveals a fascinating crossroads between neuroscience, psychology, and the search for meaning. Psychedelic-assisted therapy may transform how nicotine dependence is treated. This webinar delves into the processes believed to drive psilocybin’s therapeutic impact—from emotional regulation and brain plasticity to the role of mystical experiences—and takes a critical look at the scientific evidence that supports its promise for nicotine cessation. Thoughtful, balanced, and grounded in clinical relevance, this presentation helps clarify both the potential and the current limitations of psychedelic treatments as they make their way into behavioral health.

Learning Objectives

1. Understand emerging theoretical frameworks that may explain how psilocybin facilitates lasting behavior change including addiction recovery. 
2. Explore the broader psychedelic landscape through an examination of how psilocybin and other psychedelics are used to treat various conditions associated with substance use and substance use itself. 
3. Review the current clinical and research evidence that supports psilocybin as a treatment for nicotine dependence, including major studies and outcomes.